Correlation Between Monopar Therapeutics and Lipella Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on Monopar Therapeutics and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Lipella Pharmaceuticals.
Diversification Opportunities for Monopar Therapeutics and Lipella Pharmaceuticals
-0.62 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Monopar and Lipella is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Lipella Pharmaceuticals go up and down completely randomly.
Pair Corralation between Monopar Therapeutics and Lipella Pharmaceuticals
Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 1.08 times more return on investment than Lipella Pharmaceuticals. However, Monopar Therapeutics is 1.08 times more volatile than Lipella Pharmaceuticals Common. It trades about 0.05 of its potential returns per unit of risk. Lipella Pharmaceuticals Common is currently generating about 0.03 per unit of risk. If you would invest 1,340 in Monopar Therapeutics on August 25, 2024 and sell it today you would earn a total of 670.00 from holding Monopar Therapeutics or generate 50.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 97.99% |
| Values | Daily Returns |
Monopar Therapeutics vs. Lipella Pharmaceuticals Common
Performance |
| Timeline |
| Monopar Therapeutics |
| Lipella Pharmaceuticals |
Monopar Therapeutics and Lipella Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monopar Therapeutics and Lipella Pharmaceuticals
The main advantage of trading using opposite Monopar Therapeutics and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.| Monopar Therapeutics vs. Eliem Therapeutics | Monopar Therapeutics vs. HCW Biologics | Monopar Therapeutics vs. Scpharmaceuticals | Monopar Therapeutics vs. Milestone Pharmaceuticals |
| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |